Suppr超能文献

社区药店作为成瘾治疗的切入点。

Community pharmacies as access points for addiction treatment.

机构信息

Social and Administrative Sciences Division, University of Wisconsin-Madison School of Pharmacy, Madison, WI, United States.

University of Wisconsin-Madison School of Pharmacy, Madison, WI, United States.

出版信息

Res Social Adm Pharm. 2019 Apr;15(4):404-409. doi: 10.1016/j.sapharm.2018.06.006. Epub 2018 Jun 12.

Abstract

BACKGROUND

There is growing interest in utilizing community pharmacies to support opioid abuse prevention and addiction treatment efforts. However, it is unknown whether the placement of community pharmacies is conducive to taking on such a role.

OBJECTIVE

To examine the distribution of community pharmacies in Wisconsin and its relationship with the location of addiction treatment facilities and opioid-related overdose events in rural and urban areas.

METHODS

The total number of opioid-related overdose deaths and crude death rates per 100,000 population were determined for each county in Wisconsin. Substance abuse treatment facilities were identified in each county to estimate access to formal addiction treatment. A list of pharmacies in the state was screened to identify community pharmacies in each county. Descriptive statistics and Pearson correlation coefficients were used to describe the distribution of and relationships between county-level opioid-related overdose death rates and the number of treatment facilities and community pharmacies in the state.

RESULTS

Wisconsin has 72 counties, of which 45 (62.5%) are classified as rural. Although the number of opioid-related overdose deaths was highly concentrated in urban areas, crude death rates per 100,000 population were similar in urban and rural areas. Rural counties were significantly less likely to have formal substance abuse treatment facilities (r = -.42, P = .00) or community pharmacies (r = -.44, P = .00) compared to urban counties. However, community pharmacies were more prevalent and more likely to be located in rural counties with higher rates of opioid-related overdose deaths than substance abuse treatment facilities. All but 1 of the 14 counties without a formal substance abuse treatment facility had access to 1 or more community pharmacies.

CONCLUSIONS

Community pharmacies are ideally located in areas that could be used to support medication-assisted addiction treatment efforts, particularly in rural areas lacking formal substance abuse treatment facilities.

摘要

背景

利用社区药店来支持阿片类药物滥用预防和成瘾治疗工作的兴趣日益浓厚。然而,目前尚不清楚社区药店的布局是否有利于承担这一角色。

目的

研究威斯康星州社区药店的分布情况及其与农村和城市地区成瘾治疗设施和阿片类药物相关过量用药事件位置的关系。

方法

确定威斯康星州每个县的阿片类药物相关过量死亡人数和每 10 万人的粗死亡率。确定每个县的药物滥用治疗设施,以估计获得正规成瘾治疗的机会。筛选该州的药店名单,以确定每个县的社区药店。使用描述性统计和 Pearson 相关系数来描述县一级阿片类药物相关过量死亡率与州内治疗设施和社区药店数量的分布和关系。

结果

威斯康星州有 72 个县,其中 45 个(62.5%)被归类为农村。尽管阿片类药物相关过量死亡人数高度集中在城市地区,但每 10 万人的粗死亡率在城市和农村地区相似。与城市县相比,农村县的正规药物滥用治疗设施(r=-.42,P=0.00)或社区药店(r=-.44,P=0.00)明显较少。然而,与药物滥用治疗设施相比,农村县的社区药店更为普遍,且更有可能位于阿片类药物相关过量死亡率较高的地区。在没有正规药物滥用治疗设施的 14 个县中,除 1 个县外,其余县都有 1 家或多家社区药店。

结论

社区药店理想地位于可以支持药物辅助成瘾治疗工作的地区,特别是在缺乏正规药物滥用治疗设施的农村地区。

相似文献

1
Community pharmacies as access points for addiction treatment.
Res Social Adm Pharm. 2019 Apr;15(4):404-409. doi: 10.1016/j.sapharm.2018.06.006. Epub 2018 Jun 12.
2
Illustrating access to community pharmacies in Wisconsin.
J Am Pharm Assoc (2003). 2021 Jul-Aug;61(4):492-499. doi: 10.1016/j.japh.2021.02.004. Epub 2021 Feb 17.
3
Drug disposal deserts: An assessment of receptacle availability in Kentucky community pharmacies.
J Rural Health. 2024 Jan;40(1):208-214. doi: 10.1111/jrh.12786. Epub 2023 Jul 25.
4
Rural and Appalachian Disparities in Neonatal Abstinence Syndrome Incidence and Access to Opioid Abuse Treatment.
J Rural Health. 2018 Dec;34(1):6-13. doi: 10.1111/jrh.12251. Epub 2017 Jul 7.
5
High-risk use by patients prescribed opioids for pain and its role in overdose deaths.
JAMA Intern Med. 2014 May;174(5):796-801. doi: 10.1001/jamainternmed.2013.12711.
6
Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden.
Drug Alcohol Depend. 2021 Jul 1;224:108729. doi: 10.1016/j.drugalcdep.2021.108729. Epub 2021 Apr 24.
8
Vital Signs: Pharmacy-Based Naloxone Dispensing - United States, 2012-2018.
MMWR Morb Mortal Wkly Rep. 2019 Aug 9;68(31):679-686. doi: 10.15585/mmwr.mm6831e1.
9
Implementing take-home naloxone in an urban community pharmacy.
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S161-S167. doi: 10.1016/j.japh.2017.01.006. Epub 2017 Feb 13.
10
Are Rural Opioid Treatment Program (OTP) Facilities Associated with Lower Deaths?
Subst Use Misuse. 2020;55(5):828-838. doi: 10.1080/10826084.2019.1703751. Epub 2019 Dec 20.

引用本文的文献

1
Pharmacy-based preventive services for opioid use disorder: a survey of U.S. pharmacists.
Addict Sci Clin Pract. 2024 Dec 2;19(1):88. doi: 10.1186/s13722-024-00519-w.
4
8
Rural-Urban Disparities in Access to Medicaid-Contracted Pharmacies in Washington State, 2017.
Prev Chronic Dis. 2020 Aug 20;17:E92. doi: 10.5888/pcd17.200066.
9
Opioid prescribing and opioid-overdose deaths in Michigan: Urban-rural comparisons and changes across 2013-2017.
Addict Behav Rep. 2019 Nov 15;11:100234. doi: 10.1016/j.abrep.2019.100234. eCollection 2020 Jun.
10
Access to specialty healthcare in urban versus rural US populations: a systematic literature review.
BMC Health Serv Res. 2019 Dec 18;19(1):974. doi: 10.1186/s12913-019-4815-5.

本文引用的文献

1
Reviewing state-mandated training requirements for naloxone-dispensing pharmacists.
Res Social Adm Pharm. 2019 Feb;15(2):222-225. doi: 10.1016/j.sapharm.2018.04.002. Epub 2018 Apr 5.
2
Promising roles for pharmacists in addressing the U.S. opioid crisis.
Res Social Adm Pharm. 2019 Aug;15(8):910-916. doi: 10.1016/j.sapharm.2017.12.009. Epub 2017 Dec 31.
3
Primary care models for treating opioid use disorders: What actually works? A systematic review.
PLoS One. 2017 Oct 17;12(10):e0186315. doi: 10.1371/journal.pone.0186315. eCollection 2017.
4
Geographic Variation in Opioid and Heroin Involved Drug Poisoning Mortality Rates.
Am J Prev Med. 2017 Dec;53(6):745-753. doi: 10.1016/j.amepre.2017.06.009. Epub 2017 Aug 7.
6
Opioids, naloxone, and beyond: The intersection of medication safety, public health, and pharmacy.
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S5-S7. doi: 10.1016/j.japh.2017.02.006.
7
Indian Health Service pharmacists engaged in opioid safety initiatives and expanding access to naloxone.
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S135-S140. doi: 10.1016/j.japh.2017.01.005.
8
The pharmacist's role in overdose: Using mapping technologies to analyze naloxone and pharmacy distribution.
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S73-S77.e1. doi: 10.1016/j.japh.2016.11.006. Epub 2017 Jan 19.
9
Prescription Drug Monitoring Programs Produce a Limited Impact on Painkiller Prescribing in Medicare Part D.
Health Serv Res. 2018 Apr;53(2):671-689. doi: 10.1111/1475-6773.12652. Epub 2017 Jan 18.
10
State legal innovations to encourage naloxone dispensing.
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S180-S184. doi: 10.1016/j.japh.2016.11.007. Epub 2017 Jan 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验